Low-dose naltrexone (LDN) is a safe, inexpensive, virtually side effect free, FDA approved drug that is extremely beneficial for patients with a variety of diseases and conditions marked by immune system dysfunction. Currently LDN is underused but is proving to be extremely promising with every clinical study that is released.
LDN works by boosting levels of endorphins, the peptides produced in the brain and adrenal glands that are best known for relieving pain and enhancing sense of well-being. It binds to and inhibits opiate receptors, which primarily function to bind to the endorphins, reducing pain and enhancing a sense of wellbeing These natural peptides are also powerful modulators of the immune system, helping the body’s ability to fight disease.
Research shows that when LDN is taken at bedtime, it attaches to opioid receptors and temporarily blocks endorphins from attaching, signaling the body to increase production of endorphins, which helps orchestrate the activity of stem cells, macrophages, natural killer cells, T and B cells, and other immune cells. As a result, LDN enhances the body’s ability to fight disease.
LDN is gaining increasing recognition as a highly effective therapy for conditions ranging from autoimmune disorders and allergies to cancer and autism.
Patients with multiple sclerosis, rheumatoid arthritis, lupus, Crohn’s disease and other autoimmune disorders have seen reductions in flare-ups and intensity of symptoms. Those suffering with fibromyalgia and chronic fatigue report more energy and less pain. Individuals dealing with various types of cancer receive an invaluable immune boost from LDN. Because of its broad immune-enhancing properties, LDN is also excellent preventive therapy due to its broad immune-enhancing properties.
Some of the other conditions that benefit from treatment with LDN include:
• ALS (Lou Gehrig’s disease)
• Alzheimer’s disease
• Ankylosing spondylitis
• Celiac disease
• Emphysema (COPD)
• Inflammatory bowel disease
• Multiple sclerosis (MS)
• Parkinson’s disease
• Rheumatoid arthritis
Doctors achieving great results with low-dose naltrexone in both cancer patients and those with autoimmune diseases say LDN does not treat symptoms like most drugs do but that it instead modulates the basic mechanisms that result in disease. Don’t miss an important opportunity to learn more about the life changing breakthroughs being attributed to Low Dose Naltrexone!
The Healthy Choice Compounding Pharmacy is a part of a network of doctors and pharmacists working with The LDN Research Trust to promote a wider knowledge of the drug and promoting clinical trials.
Join us in Portland, Oregon September 21-24 for the LDN 2017 Conference to be held at the Sheraton Portland Airport Hotel where the biggest and best line up of conference speakers ever assembled on this important subject will be heard from. Conference speeches will also be recorded and if you cannot attend, you can participate via Livestream service. For more information on the conference and how to register visit: www.ldn2017.com